Mineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac Fibrosis

por Tesch, Greg H., Young, Morag J.
Publicado 2017

Establishing equivalent diabetes in male and female Nos3‐deficient mice results in a comparable onset of diabetic kidney injury

por Tian, Lifang, Nikolic‐Paterson, David J., Tesch, Greg H.
Publicado 2019

Suppression of Rapidly Progressive Mouse Glomerulonephritis with the Non-Steroidal Mineralocorticoid Receptor Antagonist BR-4628

por Ma, Frank Y., Han, Yingjie, Nikolic-Paterson, David J., Kolkhof, Peter, Tesch, Greg H.
Publicado 2015

c-Jun Amino Terminal Kinase Signaling Promotes Aristolochic Acid-Induced Acute Kidney Injury

por Yang, Fan, Ozols, Elyce, Ma, Frank Y., Leong, Khai Gene, Tesch, Greg H., Jiang, Xiaoyun, Nikolic-Paterson, David J.
Publicado 2021

Corrigendum: c-Jun amino terminal kinase signaling promotes aristolochic acid-induced acute kidney injury

por Yang, Fan, Ozols, Elyce, Ma, Frank Y., Leong, Khai Gene, Tesch, Greg H., Jiang, Xiaoyun, Nikolic-Paterson, David J.
Publicado 2023

ASK1 inhibitor treatment suppresses p38/JNK signalling with reduced kidney inflammation and fibrosis in rat crescentic glomerulonephritis

por Amos, Liv A., Ma, Frank Y., Tesch, Greg H., Liles, John T., Breckenridge, David G., Nikolic‐Paterson, David J., Han, Yingjie
Publicado 2018

WNT1-inducible signaling pathway protein 1 regulates kidney inflammation through the NF-κB pathway

por Wang, Bo, Ding, Chenguang, Ding, Xiaoming, Tesch, Greg, Zheng, Jin, Tian, PuYun, Li, Yang, Ricardo, Sharon, Shen, Hsin-Hui, Xue, Wujun
Publicado 2022

Cellular delivery of relaxin-2 mRNA as a potential treatment for kidney fibrosis

por Ding, Chenguang, Wang, Bo, Lai, Xiang Feng, Guo, Yingcong, Tesch, Greg, Ding, Xiaoming, Zheng, Jin, Tian, PuXun, Ricardo, Sharon, Shen, Hsin-Hui, Xue, Wujun
Publicado 2023